The test, marketed as the Vitros Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack, detects the virus that causes COVID-19 by detecting antibodies that lead the immune response against the virus.
Clinicians can use the test in epidemiological research to understand how the disease is spreading. The test uses Ortho’s flagship analyzer, which can process 150 tests in an hour.
More articles on healthcare:
New York neurosurgeon recovers from COVID-19, volunteers at hospital ICU
Dr. Geoff Van Thiel: COVID-19 crisis paves way for ‘long-lasting changes’ in telemedicine
Spine surgeons and the coronavirus: 8 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
